M Holdings Securities, Inc. Catalyst Biosciences, Inc. Transaction History

M Holdings Securities, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 24, 2022	SELL	$0.51 - $1.0 $43,453 - $85,202	-85,202 Closed	0 $0
Q2 2021 Aug 19, 2021	SELL	$4.1 - $5.33 $36,900 - $47,970	-9,000 Reduced 9.55%	85,202 $369,000
Q1 2021 May 12, 2021	SELL	$4.93 - $7.15 $165,155 - $239,525	-33,500 Reduced 26.23%	94,202 $475,000
Q4 2020 Feb 26, 2021	BUY	$4.55 - $7.29 $910 - $1,458	200 Added 0.16%	127,702 $806,000
Q3 2020 Nov 16, 2020	SELL	$4.22 - $6.04 $84,176 - $120,479	-19,947 Reduced 13.53%	127,502 $548,000
Q2 2020 Aug 21, 2020	BUY	$3.76 - $8.01 $554,408 - $1.18 Million	147,449 New	147,449 $866,000

215

Ticker CBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,477,100
Description
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB ...

Get notified when there are updates to the investment portfolio of M Holdings Securities, Inc., based on Form 13F filings with the SEC.

Stay updated on M Holdings Securities, Inc. with notifications on news.